28 julio 2015
The safety and dosing of a new drug for treating blood cancers has now been established by a group of scientists. The drug is a small molecule inhibitor that suppresses the activity of a signaling pathway believed to contribute to a variety of blood cancers’ eventual resistance to standard chemotherapy treatments.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/z0a21AjSBco» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/z0a21AjSBco/150728091814.htm
